对心房患者长期抗凝治疗出血并发症的回顾性队列研究
Megha Joy1, Bethamcherla Bala Chandrudu2, Mohamed Thoufeek Hussain Amjat Ibrahim3
1Department of Internal Medicine, Queen Elizabeth Queen Mother Hospital, Margate, United Kingdom.
Bioinformation
|December 30, 2025
概括
服用抗凝剂的心房患者的出血风险与不稳定的国际正常化比率 (INR) 和药物类型有关. 华法林比直接口服抗凝剂 (DOAC) 具有更高的出血风险,突出了个性化治疗的必要性.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 心房动 (AF) 需要长期抗凝药来预防中风.
- 在AF患者中,出血是抗凝药治疗的重要并发症.
- 了解出血风险因素对于优化患者安全至关重要.
研究的目的:
- 确定长期服用口服抗凝剂的AF患者出血并发症的频率和贡献因素.
- 为了比较华法林和直接口服抗凝剂 (DOAC) 之间的出血风险.
主要方法:
- 对142名AF患者的医疗记录进行了回顾性分析.
- 在三年内评估出血发作.
- 对抗凝血剂类型 (华法林与DOACs) 和国际规范化比率 (INR) 稳定性的评估.
主要成果:
- 出血并发症与不稳定的INR值有关.
- 与DOACs相比,华法林治疗与更高频率的出血事件有关.
- 患者特定的特征也对出血风险产生了影响.
结论:
- 不稳定的INR和华法林使用是AF患者出血的重要危险因素.
- DOACs可能提供一个更安全的替代方案,降低出血率.
- 量身定制的抗凝策略对于管理AF出血风险至关重要.
相关概念视频
Venous Thrombosis III: Interprofessional Care
254
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
254
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.0K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Venous Thrombosis IV: Nursing Management
175
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
175


